Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma

Taniguchi, Miyuki; Soo Ryang Kim; Imoto, Susumu; Ikawa, Hirotsugu; Ando, Kenji; Mita, Keiji; Fuki, Shuichi; Sasase, Noriko; Matsuoka, Toshiyuki; Kudo, Masatoshi; Hayashi, Yoshitake; Buettner, Reinhard
April 2008
World Journal of Gastroenterology;4/7/2008, Vol. 14 Issue 13, p1997
Academic Journal
AIM: To evaluate long-term follow-up of minimum-sized hepatocellular carcinoma (HCC) treated with percutaneous ethanol injection (PEI). METHODS: PEI was applied to 42 lesions in 31 patients (23 male and eight female) with HCC < 15 mm in diameter, over the past 15 years. RESULTS: Overall survival rate was 74.1% at 3 years, 49.9% at 5 years, 27.2% at 7 years and 14.5% at 10 years. These results are superior to, or at least the same as those for hepatic resection and radiofrequency ablation. Survival was affected only by liver function, but not by sex, age, etiology of Hepatitis B virus or Hepatitis C virus, α-fetoprotein levels, arterial and portal blood flow, histological characteristics, and tumor multiplicity or size. Patients in Child-Pugh class A and B had 5-, 7- and 10-years survival rates of 76.0%, 42.2% and 15.8%, and 17.1%, 8.6% and 0%, respectively (P = 0.025). CONCLUSION: Treatment with PEI is best indicated for patients with HCC < 15 mm in Child-Pugh class A.


Related Articles

  • Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors. Murakami, Yoshiaki; Uemura, Kenichiro; Sudo, Takeshi; Hashimoto, Yasushi; Nakashima, Akira; Sakabe, Ryutaro; Kobayashi, Hironori; Kondo, Naru; Nakagawa, Naoya; Sueda, Taijiro // Journal of Hepato -- Biliary -- Pancreatic Sciences;Jul2012, Vol. 19 Issue 4, p306 

    Background/Purpose: The aims of this study were to evaluate long-term outcomes and to determine prognostic factors for survival in patients with resected biliary carcinoma who received adjuvant gemcitabine plus S-1 chemotherapy. Methods: Seventy patients with International Union Against Cancer...

  • First Experience of Ultrasound-guided Percutaneous Ablation for Recurrent Hepatoblastoma after Liver Resection in Children. Kuang, Ming; Liu, Baoxian; Zhou, Luyao; Huang, Guangliang; Jiang, Chunlin; Shan, Quanyuan; Xu, Ming; Xie, Xiaoyan; Zhong, Zhihai // Scientific Reports;11/20/2015, p16805 

    This study aimed to summarize the first experience with ultrasound-guided percutaneous ablation treatment (PAT) for recurrent hepatoblastoma (HB) after liver resection in children. From August 2013 to October 2014, PAT was used to treat 5 children with a total of 8 recurrent HB (mean size, 1.4...

  • Development of an ex vivo simulated training model for laparoscopic liver resection. Strickland, Andrew; Fairhurst, Katherine; Lauder, Chris; Hewett, Peter; Maddern, Guy // Surgical Endoscopy;May2011, Vol. 25 Issue 5, p1677 

    Background: The number of patients who have undergone laparoscopic liver surgery has increased in the last 15 years. It is technically challenging surgery, requiring both advanced laparoscopic and liver resection skills. Surgeons often require familiarisation with much of the equipment and...

  • Perioperative Outcome of Laparoscopic Left Lateral Liver Resection Is Improved by Using Staple Line Reinforcement Technique: A Case Report Consten, Esther C.J.; Gagner, Michel // Journal of Gastrointestinal Surgery;Mar2005, Vol. 9 Issue 3, p360 

    Current laparoscopic stapling technology still cannot prevent bile leakage (<55%) along the resection margin. A new staple line reinforcement technique was used in the present case. This technique incorporates an absorbable polymer membrane into the stapler system, such that it buttresses the...

  • Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study. Takahashi, Takao; Shibata, Yoshihisa; Tojima, Yuichiro; Tsuboi, Kenji; Sakamoto, Eiji; Kunieda, Katsuyuki; Matsuoka, Hiroshi; Suzumura, Kazuyoshi; Sato, Mikinori; Naganuma, Tatsushi; Sakamoto, Junichi; Morita, Satoshi; Kondo, Ken // International Journal of Clinical Oncology;Apr2013, Vol. 18 Issue 2, p335 

    Background: Neoadjuvant chemotherapy for unresectable colorectal liver metastases can reduce tumor size, which sometimes leads to curative resection. The aim of the present study was to identify and describe patients with initially unresectable liver-only metastases from colorectal cancer who...

  • Resection of Nonalcoholic Steatohepatitis-Associated Hepatocellular Carcinoma: A Western Experience. Shrager, Brian; Jibara, Ghalib A.; Tabrizian, Parissa; Roayaie, Sasan; Ward, Stephen C. // International Journal of Surgical Oncology;2012, p1 

    Introduction. Hepatocellular carcinoma is now known to arise in association with nonalcoholic steatohepatitis. The aim of this study is to examine the clinicopathological features of this entity using liver resection cases at a large Western center. Methods. We retrospectively reviewed all cases...

  • Mesohepatectomy with total caudate lobectomy of the liver for hepatocellular carcinoma. Ishii, Hiromichi; Ogino, Shinpei; Ikemoto, Koki; Toma, Atsushi; Nakamura, Kenji; Itoh, Tsuyoshi; Ochiai, Toshiya // World Journal of Surgical Oncology;2013, Vol. 11 Issue 1, Special section p1 

    Background: Mesohepatectomy with total resection of the caudate lobe and extrahepatic bile duct is sometimes performed for hilar cholangiocarcinoma or gallbladder carcinoma; however, only a few reports on mesohepatectomy with total caudate lobectomy of the liver for hepatocellular carcinoma are...

  • An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus. Lin, De-Xin; Zhang, Qi-Yu; Li, Xuan; Ye, Qi-Wen; Lin, Fen; Li, Lin-Li // Journal of Cancer Research & Clinical Oncology;Jan2011, Vol. 137 Issue 1, p139 

    Purpose: Many physicians express a relatively nihilistic approach to the treatment of hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). Consensus among surgeons regarding the indications for an aggressive approach has not been reached. Current study was aimed to determine...

  • A population-based analysis on the rate and surgical management of colorectal liver metastases in Southern Germany. Hackl, Christina; Gerken, Michael; Loss, Martin; Klinkhammer-Schalke, Monika; Piso, Pompiliu; Schlitt, Hans // International Journal of Colorectal Disease;Nov2011, Vol. 26 Issue 11, p1475 

    Purpose: Early detection and multidisciplinary treatment of colorectal liver metastases (CLM), preferably resection, can significantly prolong the survival of colorectal cancer patients. The purpose of this study was to analyze the incidence, management and long-term clinical outcome of CLM...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics